How Can We Make More Rapid Progress in the Leveraging of Real-World Evidence by Regulatory Decision Makers?

Berger, Marc L; Crown, William

Berger, Marc L; Crown, William.

Berger ML; Independent Consultant, New York, NY, USA. Electronic address: mlberger301@gmail.com.
Crown W; The Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA.

Value Health ; 25(2): 167-170, 2022 02.

Article in English | MEDLINE | ID: covidwho-1457218

Subject(s)

Decision Making; Evidence-Based Medicine/methods; Randomized Controlled Trials as Topic/methods; Bias; Female; Humans; Male; Observational Studies as Topic; Research Design; United States; United States Food and Drug Administration

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Randomized Controlled Trials as Topic / Evidence-Based Medicine / Decision Making Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials / Systematic review/Meta Analysis Limits: Female / Humans / Male Country/Region as subject: North America Language: English Journal: Value Health Journal subject: Pharmacology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google